Adagene | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Panacea Venture Healthcare Fund II, L.P.(7.3%),Panacea Venture Healthcare Fund II GP Company, Ltd.(7.3%), etc.
Adagene | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Peter Luo(21.28%),HAN 2020 Irrevocable Trust(10.88%)
Adagene | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(6.414%),Abigail P. Johnson(6.414%)
Adagene | SC 13G: Statement of acquisition of beneficial ownership by individuals-Panacea Venture Healthcare Fund II, L.P.(5.0%),Panacea Venture Healthcare Fund II GP Company, Ltd.(5.0%), etc.
Adagene | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Peter Luo(22.77%),HAN 2020 GRAT(0%)
Adagene | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(8.785%),Abigail P. Johnson(8.785%)
Adagene | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JSR Limited(9.9%),GP Healthcare Capital Co., Ltd.(9.9%)
Adagene | SC 13D: Statement of acquisition of beneficial ownership by individuals-Peter Luo(20.80%),HAN 2020 GRAT(9.51%)
Adagene | SC 13G: Statement of acquisition of beneficial ownership by individuals-General Atlantic Singapore Fund Pte. Ltd.(8.8%),General Atlantic Singapore Interholdco Ltd.(8.8%), etc.
Adagene | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(9.089%),Abigail P. Johnson(9.089%)
Adagene | SC 13G: Statement of acquisition of beneficial ownership by individuals-Peter Luo(20.22%),HAN 2020 GRAT(9.54%)
Adagene | SC 13G: Statement of acquisition of beneficial ownership by individuals-WuXi PharmaTech Healthcare Fund I L.P.(9.67%),WuXi AppTec Co., Ltd.(9.67%)
Adagene | SC 13G: Statement of acquisition of beneficial ownership by individuals-JSR Limited(9.81%),GP Healthcare Capital Co., Ltd.(9.81%)
Adagene | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Adagene | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions